Fox Run Management, L.L.C. Amphastar Pharmaceuticals, Inc. Transaction History
Fox Run Management, L.L.C.
- $553 Million
- Q2 2025
A detailed history of Fox Run Management, L.L.C. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 21,199 shares of AMPH stock, worth $503,052. This represents 0.09% of its overall portfolio holdings.
Number of Shares
21,199Holding current value
$503,052% of portfolio
0.09%Shares
4 transactions
Others Institutions Holding AMPH
# of Institutions
262Shares Held
32.9MCall Options Held
18.3KPut Options Held
13K-
Black Rock Inc. New York, NY5.94MShares$141 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$63.8 Million0.0% of portfolio
-
Td Asset Management Inc2.03MShares$48.3 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$38.6 Million0.01% of portfolio
-
State Street Corp Boston, MA1.58MShares$37.4 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.16B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...